Sodium–Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK–mTOR Signaling Pathway–Mediated Autophagy

Overview of attention for article published in Frontiers in Pharmacology, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 62 Dimensions

Readers on

mendeley: 45 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,885 followers.

Sodium-Glucose CoTransporter-2 Inhibitor Empagliflozin Ameliorates Sunitinib-Induced Cardiac Dysfunction via Regulation of AMPK-mTOR Signaling Pathway-Mediated Autophagy https://t.co/f8mVMkglPp From @FrontPharmacol

25 May 2021

Reply Repost Favourite

Similar to what we showed at @CovUni_SELS activation of AMPK prevents tyrosine kinase inhibitor toxicity by inhibition of Sodium Glucose Cotransporter https://t.co/dZAXvNA2Jo

03 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.